VI
ACHN

Versor Investments’s Achillion Pharmaceuticals ACHN Stock Holding History

Versor Investments’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,515,675
Closed -$45.3M – 382
2019
Q4 		$45.3M Buy
+7,515,675
New +$43.5M 2.29% 19

Versor Investments's ACHN Position: Q1 2020 in Review

Versor Investments sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 7,515,675 shares — an estimated $45.3M sold.

Versor Investments first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $45.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Versor Investments reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Versor Investments sold 7,515,675 Achillion Pharmaceuticals shares in Q1 2020, an estimated $45.3M.
  • Versor Investments first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Versor Investments's Achillion Pharmaceuticals position peaked at $45.3M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Versor Investments's 13F filing for Q1 2020, filed 28 Apr 2020.